Winner Medical Co Ltd

Winner Medical Co Ltd

300888 · SHE · Healthcare / Medical Instruments & Supplies

29.34CNY-0.07 (-0.24%)

Price History

Full chart

Market Stats

Previous Close29.41
Open29.42
Day Range29.16 – 29.68
52-Week Range25.65 – 42.34
Volume2.56M
Market Cap17.05B
P/E (TTM)21.51
Forward P/E0.00
EPS1.36
Dividend Yield2.74%
Beta-0.02
50-Day Avg29.44
200-Day Avg32.00

About

Winner Medical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of disposable medical products in China and internationally. It operates in two segments, Medical Consumables and Consumer Products. The company offers wound care solutions, including gauzes, bandages, adhesive and film dressings, cotton and non-woven products, basic kits, liquid skin protectants, debridement and exudate management products, anti-adhesion wound care, scar repair products, antimicrobial solutions, and biological active and compression treatment products; and operating room solutions, such as masks, gloves, protective apparel, surgical gowns and drapes, speciality drapes and packs, operating room solution accessories, general surgical kits and trays, and surgical consumables for pets. It also provides home care solutions comprising wound care products, which includes adhesive and silicone bandages, as well as first aid kits; and personal care products, such as incontinence, cosmetics, other cotton products, and foot, daily, sports, ear, nose, and throat care products, as well as hygiene products comprising panty liners, sanitary napkins, tampons, breast and maternity pads, disposable underwear, and baby diapers. In addition, the company is involved in technology promotion services; engineering and technology research and experimental development; manufacturing of medical instruments, equipment, and devices; software and information technology services; production of rubber and chemical products; and trading and consulting services. It sells its products under the Winner Medical, Purcotton, and PureH2B brands through sales teams, hospitals, e-commerce, and pharmacy and chain stores. The company serves the hospital, pharmacy, PPE, consumer, and industrial field industries. It exports its products. The company was founded in 1991 and is headquartered in Shenzhen, China. Winner Medical Co., Ltd. is a subsidiary of Winner Group Limited.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Jianquan Li
  • Employees15.86K
  • HeadquartersBuilding 2, Huilong Business Center, Shenzhen, China, 518131, China
  • Websitehttps://www.winnermedical.com

Leadership

  • Mr. Jianquan LiChairman, CEO & GM · b. 1957
  • Mr. Xiuyuan FangNon-Independent Director, Deputy GM & CFO · b. 1968
  • Ms. Liao MeizhenNon-Independent Director · b. 1982
  • Ms. Huixuan ChenDeputy GM & Secretary · b. 1982
  • Mr. Guan Lai LiaoDeputy General Manager · b. 1982
  • Ms. Xia YanDeputy General Manager · b. 1975
  • Yan ZhaoAccounting Supervisor

Financials

Income Statement

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.27B1.51B1.82B2.56B3.50B3.84B4.57B12.53B8.04B11.35B8.19B8.98B10.95B
Growth (%)-+18.70%+20.48%+40.72%+36.63%+9.76%+19.16%+173.99%-35.87%+41.23%-27.89%+9.69%+21.96%
Cost of Revenue887.71M998.60M1.07B1.33B1.84B1.97B2.24B5.21B4.12B6.34B4.39B4.88B5.73B
Gross Profit384.26M511.27M753.75M1.23B1.65B1.87B2.34B7.32B3.92B5.01B3.79B4.10B5.22B
Gross Margin30.21%33.86%41.44%48.23%47.31%48.68%51.04%58.42%48.73%44.15%46.33%45.65%47.64%
Operating Expense288.41M359.89M502.48M742.66M1.14B1.37B1.69B2.79B2.44B3.03B2.97B3.18B3.91B
Operating Income95.85M151.38M251.27M492.06M516.12M495.71M641.77M4.53B1.48B1.98B817.97M914.86M1.31B
Operating Margin7.54%10.03%13.81%19.22%14.76%12.91%14.03%36.16%18.36%17.41%9.99%10.19%11.93%
EBITDA118.61M178.38M294.79M543.63M607.22M608.83M756.19M4.67B1.66B2.24B1.13B1.32B1.77B
EBITDA Margin9.33%11.81%16.21%21.24%17.36%15.86%16.53%37.23%20.66%19.73%13.81%14.66%16.13%
Net Income88.14M129.06M220.54M409.64M427.20M424.68M546.29M3.81B1.24B1.65B580.40M695.38M767.97M
Net Income Margin6.93%8.55%12.12%16.00%12.21%11.06%11.94%30.40%15.42%14.54%7.09%7.75%7.01%
R&D-48.25M52.79M61.08M88.63M116.56M155.19M411.38M298.16M487.58M322.05M348.16M410.88M
R&D as % of Total Revenue-3.20%2.90%2.39%2.53%3.04%3.39%3.28%3.71%4.30%3.93%3.88%3.75%
Interest Expense20.28M873.72K-1.85M12.75M18.65M14.35M5.37M31.09M53.41M64.43M58.07M55.11M
Interest Expense % of Total Revenue1.59%0.06%-0.07%0.36%0.49%0.31%0.04%0.39%0.47%0.79%0.65%0.50%

Balance Sheet

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.14B1.51B1.68B2.30B3.39B3.96B4.53B13.51B13.27B18.25B17.11B18.39B18.40B
Total Liabilities402.32M364.67M371.15M647.45M1.41B1.30B1.37B3.10B2.58B6.05B5.00B6.52B6.11B
Total Equity741.49M1.14B1.31B1.65B1.97B2.66B3.16B10.39B10.67B11.72B11.53B11.15B11.52B
Cash117.25M175.31M186.56M328.52M450.49M403.83M480.84M4.16B4.27B4.53B4.71B1.41B1.59B
Total Debt227.50M140.00M20.00M60.00M394.99M299.59M254.21M513.90M381.81M2.62B1.96B2.46B-
Net Debt110.25M-35.31M-166.56M-268.52M-55.50M-104.24M-226.63M-3.65B-3.89B-1.91B-2.75B1.05B292.64M

Cash Flow

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow124.39M203.96M269.29M450.14M357.80M467.86M599.77M4.77B871.69M2.98B1.06B1.27B1.67B
Investing Cash Flow-116.78M-308.11M-91.55M-298.24M-483.33M-637.22M-419.67M-4.43B478.81M-3.82B1.03B-4.11B-
Financing Cash Flow27.39M124.27M-125.33M-22.17M218.42M143.32M-98.40M3.35B-1.41B1.12B-1.79B-477.52M-
Capital Expenditure120.69M138.17M267.31M287.97M530.04M638.14M446.90M573.26M743.27M1.20B753.07M900.89M647.91M
Free Cash Flow3.70M65.80M1.98M162.17M-172.24M-170.28M152.87M4.19B128.42M1.78B310.26M364.87M1.02B
Dividends Paid50.40M48.79M60.90M58.68M114.37M58.35M43.00M102.33M767.69M377.76M821.62M412.66M606.83M
FCF to OCF2.97%32.26%0.73%36.03%-48.14%-36.40%25.49%87.98%14.73%59.80%29.18%28.83%61.10%
Dividend Paid to FCF1363.01%74.15%3080.19%36.18%-66.40%-34.27%28.13%2.44%597.79%21.17%264.82%113.10%59.62%

Earnings

Report DateOct 28, 2020Apr 26, 2021Aug 20, 2021Oct 25, 2021Apr 21, 2022Aug 17, 2022Oct 24, 2022Apr 24, 2023Aug 15, 2023Oct 23, 2023Apr 24, 2024Aug 28, 2024Oct 28, 2024Apr 28, 2025Aug 22, 2025Oct 28, 2025Apr 22, 2026Aug 25, 2026
EPS Estimate------------------
EPS Actual4.971.130.660.800.841.280.850.900.522.510.310.350.290.240.420.410.430.45
Surprise------------------
TimingPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-market-Pre-marketAfter-hours----

Key Statistics & Ratios

Market Cap17.05B
Enterprise Value15.17B
Trailing P/E21.51
Forward P/E0.00
Price / Sales1.53
Price / Book1.48
EPS1.36
Book Value20.32
Revenue (TTM)11.14B
Gross Profit (TTM)5.26B
EBITDA1.66B
Profit Margin7.09%
Operating Margin9.79%
Return on Equity6.79%
Return on Assets4.14%
Shares Outstanding582.97M
Shares Float159.03M
Beta-0.02
Dividend Yield2.74%
Dividend Rate0.80
Payout Ratio61.82%

Dividends

20262×
0.50Sep 2, 20260.30May 25, 2026
20252×
0.45Sep 3, 20250.25May 30, 2025
20242×
0.40Sep 30, 20240.50Jun 4, 2024
20231×
1.90Jun 2, 2023
20221×
0.64May 27, 2022
20211×
1.29May 20, 2021

Stock Splits

  • Jun 2, 20231.4:1